ArticleBMC public health2025
Impact of remnant cholesterol on arterial stiffness and mediating role of systolic blood pressure in chinese hypertensive adults.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Interaction of hypertension and remnant cholesterol on arterial stiffness in Chinese middle-aged and elderly populations.Lipids in health and disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThis study aimed to investigate the association between remnant cholesterol (RC) levels and arterial stiffness in hypertensive patients and to explore potential effect modifiers.
methodsA cohort of 18,152 individuals diagnosed with hypertension was analyzed. RC was calculated using the Martin-Hopkins method, i.e., RC = total cholesterol (TC)-high-density lipoprotein cholesterol (HDL-C)-low-density lipoprotein cholesterol (LDL-C). Multivariate logistic regression models were employed to mitigate the influence of potential confounding factors and assess the association between RC and arterial stiffness (baPWV ≥ 1800 cm/s). Mediating analysis was conducted to determine the extent to which systolic blood pressure (SBP) mediates the correlation between RC and arterial stiffness.
resultsAmong 18152 study participants, 50.0% of males had an RC < 0.78 mmol/L, with a mean (SD) age of 59.6 (9.6) years. A significant positive correlation was observed between elevated RC levels and an increased risk of arterial stiffness (OR = 1.31; 95% CI: 1.14, 1.50). This positive correlation was also evident in hypertensive populations with SBP ≥ 140 mmHg (OR = 1.45; 95% CI: 1.21, 1.70). However, in populations with SBP < 140 mmHg, the association between RC and arterial stiffness appeared to require additional research and validation (OR = 1. 11; 95% CI: 0.86, 1.43). The results of the mediation analysis indicated that SBP mediated 21.54% of the correlation between RC and arterial stiffness.
conclusionsThis study demonstrated a positive association between RC and an increased risk of arterial stiffness among Chinese adults diagnosed with hypertension, particularly those with inadequate blood pressure control. SBP plays a mediating role in the association between RC and arterial stiffness. KEY POINTS: RC is positively associated with arterial stiffness in hypertensive adults, particularly those with poor blood pressure control. Independent of other traditional lipid markers, RC may serve as a target for the prevention of developing arterial stiffness in hypertensive patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.